|
1
|
Vestbo J, Hurd SS and Rodriguez-Roisin R:
The 2011 revision of the global strategy for the diagnosis,
management and prevention of COPD (GOLD)-why and what? Clin Respir
J. 6:208–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Duvoix A, Dickens J, Haq I, Mannino D,
Miller B, Tal-Singer R and Lomas DA: Blood fibrinogen as a
biomarker of chronic obstructive pulmonary disease. Thorax.
68:670–676. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo Y, Zhang T, Wang Z, Yu F, Xu Q, Guo W,
Wu C and He J: Body mass index and mortality in chronic obstructive
pulmonary disease: A dose-response meta-analysis. Medicine
(Baltimore). 95:e42252016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bhatt SP and Dransfield MT: Chronic
obstructive pulmonary disease and cardiovascular disease. Transl
Res. 162:237–251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rabe KF and Watz H: Chronic obstructive
pulmonary disease. Lancet. 389:1931–1940. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Russi EW, Karrer W, Brutsche M, Eich C,
Fitting JW, Frey M, Geiser T, Kuhn M, Nicod L, Quadri F, et al:
Diagnosis and management of chronic obstructive pulmonary disease:
The Swiss guidelines. Official guidelines of the Swiss Respiratory
Society. Respiration. 85:160–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Casanova C, Marin JM, Martinez-Gonzalez C,
de Lucas-Ramos P, Mir-Viladrich I, Cosio B, Peces-Barba G,
Solanes-García I, Agüero R, Feu-Collado N, et al: Differential
effect of modified medical research council dyspnea, COPD
assessment test, and clinical COPD questionnaire for symptoms
evaluation within the new GOLD staging and mortality in COPD.
Chest. 148:159–168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fullerton DG, Gordon SB and Calverley PM:
Chronic obstructive pulmonary disease in non-smokers. Lancet.
374:1964–1966. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barnes PJ: Cellular and molecular
mechanisms of chronic obstructive pulmonary disease. Clin Chest
Med. 35:71–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao X, Gao S, Ren H, Sun W, Zhang H, Sun
J, Yang S and Hao J: Hypoxia-inducible factor-1 promotes pancreatic
ductal adenocarcinoma invasion and metastasis by activating
transcription of the actin-bundling protein fascin. Cancer Res.
74:2455–2464. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gui D, Li Y, Chen X, Gao D, Yang Y and Li
X: HIF-1 signaling pathway involving iNOS, COX-2 and caspase-9
mediates the neuroprotection provided by erythropoietin in the
retina of chronic ocular hypertension rats. Mol Med Rep.
11:1490–1496. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Semenza GL: Hypoxia-inducible factor 1 and
cardiovascular disease. Annu Rev Physiol. 76:39–56. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee SH, Lee SH, Kim CH, Yang KS, Lee EJ,
Min KH, Hur GY, Lee SH, Lee SY, Kim JH, et al: Increased expression
of vascular endothelial growth factor and hypoxia inducible
factor-1α in lung tissue of patients with chronic bronchitis. Clin
Biochem. 47:552–559. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kranenburg AR, de Boer WI, Alagappan VK,
Sterk PJ and Sharma HS: Enhanced bronchial expression of vascular
endothelial growth factor and receptors (Flk-1 and Flt-1) in
patients with chronic obstructive pulmonary disease. Thorax.
60:106–113. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Johannessen A, Nilsen RM, Storebø M,
Gulsvik A, Eagan T and Bakke P: Comparison of 2011 and 2007 Global
Initiative for Chronic Obstructive Lung Disease guidelines for
predicting mortality and hospitalization. Am J Respir Crit Care
Med. 188:51–59. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu WC, Fu SN, Tai EL, Yeung YC, Kwong KC,
Chang Y, Tam CM and Yiu YK: Spirometry is underused in the
diagnosis and monitoring of patients with chronic obstructive
pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis.
8:389–395. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jones PW, Harding G, Berry P, Wiklund I,
Chen WH and Leidy Kline N: Development and first validation of the
COPD assessment test. Eur Respir J. 34:648–654. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma Y, Ma L, Guo Q and Zhang S: Expression
of bone morphogenetic protein-2 and its receptors in epithelial
ovarian cancer and their influence on the prognosis of ovarian
cancer patients. J Exp Clin Cancer Res. 29:852010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Salvi S: Tobacco smoking and environmental
risk factors for chronic obstructive pulmonary disease. Clin Chest
Med. 35:17–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Burney P, Jithoo A, Kato B, Janson C,
Mannino D, Nizankowska-Mogilnicka E, Studnicka M, Tan W, Bateman E,
Koçabas A, et al: Chronic obstructive pulmonary disease mortality
and prevalence: The associations with smoking and poverty-a BOLD
analysis. Thorax. 69:465–473. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lange P, Celli B, Agustí A, Jensen Boje G,
Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor
P, et al: Lung-function trajectories leading to chronic obstructive
pulmonary disease. N Engl J Med. 373:111–122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sundar IK, Yao H and Rahman I: Oxidative
stress and chromatin remodeling in chronic obstructive pulmonary
disease and smoking-related diseases. Antioxid Redox Signal.
18:1956–1971. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pelegrino NR, Tanni SE, Amaral RA,
Angeleli AY, Correa C and Godoy I: Effects of active smoking on
airway and systemic inflammation profiles in patients with chronic
obstructive pulmonary disease. Am J Med Sci. 345:440–445. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Higashimoto Y, Iwata T, Okada M, Satoh H,
Fukuda K and Tohda Y: Serum biomarkers as predictors of lung
function decline in chronic obstructive pulmonary disease. Respir
Med. 103:1231–1238. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Donaldson GC, Seemungal TA, Bhowmik A and
Wedzicha JA: Relationship between exacerbation frequency and lung
function decline in chronic obstructive pulmonary disease. Thorax.
57:847–852. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eisner MD, Iribarren C, Yelin EH, Sidney
S, Katz PP, Ackerson L, Lathon P, Tolstykh I, Omachi T, Byl N and
Blanc PD: Pulmonary function and the risk of functional limitation
in chronic obstructive pulmonary disease. Am J Epidemiol.
167:1090–1101. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen YR, Dai AG, Hu RC and Kong CC: The
expression of hypoxia-inducible factor-1alpha and its hydroxylases
in pulmonary arteries of patient with chronic obstructive pulmonary
disease. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 28:234–238.
2012.(In Chinese). PubMed/NCBI
|
|
28
|
Nguyen LK, Cavadas MA, Scholz CC,
Fitzpatrick SF, Bruning U, Cummins EP, Tambuwala MM, Manresa MC,
Kholodenko BN, Taylor CT and Cheong A: A dynamic model of the
hypoxia-inducible factor 1α (HIF-1α) network. J Cell Sci.
126:1454–1463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang L, Ge W, Hu K, Zhang Y, Li C, Xu X,
He D, Zhao Z, Zhang J, Jie F, et al: Endostar down-regulates HIF-1
and VEGF expression and enhances the radioresponse to human lung
adenocarcinoma cancer cells. Mol Biol Rep. 39:89–95. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang Y, Wang J, Tian H, Li G, Zhu H, Liu
L, Hu R and Dai A: Increased SUMO-1 expression in response to
hypoxia: Interaction with HIF-1α in hypoxic pulmonary hypertension.
Int J Mol Med. 36:271–281. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Polosukhin VV, Cates JM, Lawson WE,
Milstone AP, Matafonov AG, Massion PP, Lee JW, Randell SH and
Blackwell TS: Hypoxia-inducible factor-1 signalling promotes goblet
cell hyperplasia in airway epithelium. J Pathol. 224:203–211. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fijalkowska I, Xu W, Comhair SA, Janocha
AJ, Mavrakis LA, Krishnamachary B, Zhen L, Mao T, Richter A,
Erzurum SC and Tuder RM: Hypoxia inducible-factor1alpha regulates
the metabolic shift of pulmonary hypertensive endothelial cells. Am
J Pathol. 176:1130–1138. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hosford GE and Olson DM: Effects of
hyperoxia on VEGF, its receptors, and HIF-2alpha in the newborn rat
lung. Am J Physiol Lung Cell Mol Physiol. 285:L161–L168. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kasahara Y, Tuder RM,
Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK,
Waltenberger J and Voelkel NF: Inhibition of VEGF receptors causes
lung cell apoptosis and emphysema. J Clin Invest. 106:1311–1319.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tipoe GL and Fung ML: Expression of
HIF-1alpha, VEGF and VEGF receptors in the carotid body of
chronically hypoxic rat. Respir Physiol Neurobiol. 138:143–154.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang H, Zhu Y, Xu H, Sun Y and Li Q:
Activation of hypoxia-inducible factor-1alpha via nuclear
factor-kappa B in rats with chronic obstructive pulmonary disease.
Acta Biochim Biophys Sin (Shanghai). 42:483–488. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yamaji-Kegan K, Su Q, Angelini DJ,
Champion HC and Johns RA: Hypoxia-induced mitogenic factor has
proangiogenic and proinflammatory effects in the lung via VEGF and
VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol.
291:L1159–L1168. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Maloney JP and Gao L: Proinflammatory
cytokines increase vascular endothelial growth factor expression in
alveolar epithelial cells. Mediators Inflamm. 2015:3878422015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
McCarty G, Awad O and Loeb DM: WT1 protein
directly regulates expression of vascular endothelial growth factor
and is a mediator of tumor response to hypoxia. J Biol Chem.
286:43634–43643. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ioannou M, Papamichali R, Kouvaras E,
Mylonis I, Vageli D, Kerenidou T, Barbanis S, Daponte A, Simos G,
Gourgoulianis K and Koukoulis GK: Hypoxia inducible factor-1 alpha
and vascular endothelial growth factor in biopsies of small cell
lung carcinoma. Lung. 187:321–329. 2009. View Article : Google Scholar : PubMed/NCBI
|
